Advertisement

CardioSEAL®, CardioSEAL-STARFlex®, and PFO-Star® Closure of PFO

  • Michael J. Landzberg
Part of the Contemporary Cardiology book series (CONCARD)

Abstract

Post utero, persistence of the patent foramen ovale (PFO) carries mischievous potential, as it appears to have no physiologic or survival benefit for normal individuals. In states of abnormal right-sided cardiac capacitance, PFO has been implicated in worsening hypoxemia resulting from right to left intracardiac passage of deoxygenated blood. Association and causative roles of PFO in much more commonly occurring syndromes, including cerebral and cutaneous decompression disease, migraine with aura, and embolic ischemic stroke, have been suggested.

Keywords

Migraine With Aura Transcatheter Closure Percutaneous Closure Radial Stiffness Septum Primum 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bridges ND, Hellendbrand W, Latson L, et al. Transcatheter closure of patent foramen ovale after presumed paradoxical embolism. Circulation 1992;86:1902–1908.PubMedGoogle Scholar
  2. 2.
    Ruiz LE, Alboliras ET, Pophal SG. The puncture technique: a new method for transcatheter closure of patent foramen ovale. Cathet Cardiovasc Intervent 2001;53:369–372.CrossRefGoogle Scholar
  3. 3.
    Herrmann HC, Silvestry FE, Glaser R, et al. Percutaneous PFO and ASD closure in adults: results and device comparison in 100 consecutive implants at a single center. Cathet Cardiovasc Intervent 2004, in press.Google Scholar
  4. 4.
    Windecker S, Wahl A, Chatterjee T, et al. Percutaneous closure of patent foramen ovale in patients with paradoxical enmbolism: long-term risk of recurrent thromboembolic events. Circulation 2000:101:892–898.Google Scholar
  5. 5.
    Hung J, Landzberg MJ, Jenkins JK, et al. Closure of patent foramen ovale for paradoxical emboli: intermediate-term risk of recurrent neurological events following tanscatheter device placement. J Am Coll Cardiol 2000;35:131.CrossRefGoogle Scholar
  6. 6.
    Butera G, Bini MR, Chessa M, et al. Transcatheter closure of patent foramen ovale in patients with cryptogenic stroke. Ital Heart J 2001;2:115–118.PubMedGoogle Scholar
  7. 7.
    Martin F, Sanchez PL, Doherty E, et al. Percutaneous transcatheter closure of patent foramen ovale in patients with paradoxical embolism. Circulation 2002;106:1121–1126.PubMedCrossRefGoogle Scholar
  8. 8.
    Khairy P, O’Donnell CP, Landzberg MJ. Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboembolism: a systematic review. Ann Intern Med 2003;139:753–760.PubMedGoogle Scholar
  9. 9.
    Braun MU, Fassbender D, Schoen S, et al. Transcatheter closure of patent foramen ovale in patients with cerebral ischemia. J Am Coll Cardiol 2002;39:2019–2025.PubMedCrossRefGoogle Scholar
  10. 10.
    La Rosee K, Krause D, Becker M, et al. Transcatheter closure of atrial septal defects in adults: practicality and safety of four different closure devices used in 102 patients. Dtsch Med Wochenschr 2001; 126: 1030–1036.PubMedCrossRefGoogle Scholar
  11. 11.
    Sievert H, Horvath K, Zadan E, et al. Patent foramen ovale closure in patients with transient ischemic attack/stroke. J Intervent Cardiol 2001;14:261–266.PubMedCrossRefGoogle Scholar
  12. 12.
    Stauffier JC, Serra M, Juillard JM, et al. Percutaneous closure of patent foramen ovale: preliminary experience with PFO-Star. Arch Mal Coeur Vaiss 2004;97:37–41.Google Scholar
  13. 13.
    Schwerzmann M, Windecker S, Wahl A, et al. Percutaneous closure of patent foramen ovale: impact of device design on safety and efficacy. Heart 2004;90:186–190.PubMedCrossRefGoogle Scholar
  14. 14.
    Krumsdorf U, Ostermayer S, Billinger K, et al. Incidence and clinical course of thrombus formation on atrial septal defect and patent foramen ovale closure devices in one thousand consecutive patients. J Am Coll Cardiol 2004;43:302–309.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc., Totowa, NJ 2005

Authors and Affiliations

  • Michael J. Landzberg
    • 1
  1. 1.Boston Adult Congenital Heart Disease Service, Department of CardiologyThe Children’s Hospital and Brigham and Women’s HospitalBoston

Personalised recommendations